BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38699187)

  • 1. Plasma-based lipidomics reveals potential diagnostic biomarkers for esophageal squamous cell carcinoma: a retrospective study.
    Chen Y; Gu Y; Rong J; Xu L; Huang X; Zhu J; Chen Z; Mao W
    PeerJ; 2024; 12():e17272. PubMed ID: 38699187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of diagnostic markers and lipid dysregulation in oesophageal squamous cell carcinoma through lipidomic analysis and machine learning.
    Yuan Y; Zhao Z; Xue L; Wang G; Song H; Pang R; Zhou J; Luo J; Song Y; Yin Y
    Br J Cancer; 2021 Aug; 125(3):351-357. PubMed ID: 33953345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies against tumor-associated antigens combined with microRNAs in detecting esophageal squamous cell carcinoma.
    Sun G; Ye H; Wang X; Li T; Jiang D; Qiu C; Dai L; Shi J; Wang K; Song C; Wang P; Zhang J
    Cancer Med; 2020 Feb; 9(3):1173-1182. PubMed ID: 31856412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Validation of an Esophageal Squamous Cell Carcinoma Detection Model by Large-Scale MicroRNA Profiling.
    Sudo K; Kato K; Matsuzaki J; Boku N; Abe S; Saito Y; Daiko H; Takizawa S; Aoki Y; Sakamoto H; Niida S; Takeshita F; Fukuda T; Ochiya T
    JAMA Netw Open; 2019 May; 2(5):e194573. PubMed ID: 31125107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma.
    Wang WT; Guo CQ; Cui GH; Zhao S
    World J Gastroenterol; 2019 Oct; 25(37):5604-5618. PubMed ID: 31602161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma.
    Tong YS; Wang XW; Zhou XL; Liu ZH; Yang TX; Shi WH; Xie HW; Lv J; Wu QQ; Cao XF
    Mol Cancer; 2015 Jan; 14():3. PubMed ID: 25608466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of chemical elements in esophageal squamous cell carcinoma in Anyang, China: a case-control study based on machine learning methods.
    Lin T; Liu T; Lin Y; Zhang C; Yan L; Chen Z; He Z; Wang J
    BMJ Open; 2017 Sep; 7(9):e015443. PubMed ID: 28947442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid Identification of Biomarkers in Esophageal Squamous Cell Carcinoma by Lipidomic Analysis.
    Si T; Liu D; Li L; Xu Z; Jiang L; Zhai Y; Wu Q
    Nutr Cancer; 2024 May; ():1-11. PubMed ID: 38753560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disturbed tryptophan metabolism correlating to progression and metastasis of esophageal squamous cell carcinoma.
    Cheng J; Jin H; Hou X; Lv J; Gao X; Zheng G
    Biochem Biophys Res Commun; 2017 May; 486(3):781-787. PubMed ID: 28342863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining fecal microbiome and metabolomics reveals diagnostic biomarkers for esophageal squamous cell carcinoma.
    Gao M; Wu J; Zhou S; Chen Y; Wang M; He W; Jiang L; Shu Y; Wang X
    Microbiol Spectr; 2024 May; 12(5):e0401223. PubMed ID: 38497715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of Esophageal Squamous Cell Carcinoma by High-Performance Serum Metabolic Fingerprints: A Retrospective Study.
    Huang Y; Yang H; Li J; Wang F; Liu W; Liu Y; Wang R; Duan L; Wu J; Gao Z; Cao J; Bian F; Zhang J; Zhao F; Yang S; Cao S; Yang A; Wang X; Geng M; Hao A; Li J; Cao J; Li C; Zhang Z; Zhang N; Huang Y; Zhang Y; Qian K; Zhou F
    Small Methods; 2024 Jan; 8(1):e2301046. PubMed ID: 37803160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma free amino acid profiling of esophageal cancer using high-performance liquid chromatography spectroscopy.
    Ma H; Hasim A; Mamtimin B; Kong B; Zhang HP; Sheyhidin I
    World J Gastroenterol; 2014 Jul; 20(26):8653-9. PubMed ID: 25024622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood-based biomarkers for early detection of esophageal squamous cell carcinoma.
    Chu LY; Peng YH; Weng XF; Xie JJ; Xu YW
    World J Gastroenterol; 2020 Apr; 26(15):1708-1725. PubMed ID: 32351288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating microRNA/isomiRs as novel biomarkers of esophageal squamous cell carcinoma.
    Ibuki Y; Nishiyama Y; Tsutani Y; Emi M; Hamai Y; Okada M; Tahara H
    PLoS One; 2020; 15(4):e0231116. PubMed ID: 32251457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel rapid quantitative method reveals stathmin-1 as a promising marker for esophageal squamous cell carcinoma.
    Yan L; Dong X; Gao J; Liu F; Zhou L; Sun Y; Zhao X
    Cancer Med; 2018 May; 7(5):1802-1813. PubMed ID: 29577639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated serum eotaxin and IP-10 levels as potential biomarkers for the detection of esophageal squamous cell carcinoma.
    Chang C; Wang MJ; Bi XF; Fan ZY; Feng D; Cai HQ; Zhang Y; Xu X; Cai Y; Qi J; Wei WQ; Hao JJ; Wang MR
    J Clin Lab Anal; 2021 Sep; 35(9):e23904. PubMed ID: 34288108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating miRNAs as novel potential biomarkers for esophageal squamous cell carcinoma diagnosis: a meta-analysis update.
    Liu F; Tian T; Xia LL; Ding Y; Cormier RT; He Y
    Dis Esophagus; 2017 Feb; 30(2):1-9. PubMed ID: 27003597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of lncRNA LINC-PINT Participates in the Recurrence of Esophageal Squamous Cell Carcinoma Possibly by Interacting miRNA-21.
    Rong H; Chen B; Ma K; Wei X; Peng J; Zhu J
    Cancer Biother Radiopharm; 2021 Apr; 36(3):273-279. PubMed ID: 32401035
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of plasma metabolomic profiling for diagnosis of esophageal squamous-cell carcinoma using an UPLC/TOF/MS platform.
    Liu R; Peng Y; Li X; Wang Y; Pan E; Guo W; Pu Y; Yin L
    Int J Mol Sci; 2013 Apr; 14(5):8899-911. PubMed ID: 23615477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of extracellular matrix protein 1 as a potential plasma biomarker of ESCC by proteomic analysis using iTRAQ and 2D-LC-MS/MS.
    Wang X; Peng Y; Xie M; Gao Z; Yin L; Pu Y; Liu R
    Proteomics Clin Appl; 2017 Sep; 11(9-10):. PubMed ID: 28493612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.